Christos Hatzis, Adjunct Associate Professor Of Medicine at Yale University School of Medicine, made the following post on LinkedIn:

“I am thrilled to share that I have joined Alentis Therapeutics as the Head of Translational Medicine.

I am truly impressed with the depth and quality of the clinical pipeline, and it would be a great honor to join the exceptionally talented team to help realize the full potential of Claudin-1 as a unique target in oncology and fibrosis.”

Source: Christos Hatzis/LinkedIn